BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28469840)

  • 1. Do the equity-efficiency preferences of the Israeli Basket Committee match those of Israeli health policy makers?
    Shmueli A
    Isr J Health Policy Res; 2017; 6():20. PubMed ID: 28469840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency and equity considerations in the preferences of health policy-makers in Israel.
    Shmueli A; Golan O; Paolucci F; Mentzakis E
    Isr J Health Policy Res; 2017; 6():18. PubMed ID: 28373904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency.
    Mirelman A; Mentzakis E; Kinter E; Paolucci F; Fordham R; Ozawa S; Ferraz M; Baltussen R; Niessen LW
    Value Health; 2012 May; 15(3):534-9. PubMed ID: 22583464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision-makers' preferences for approving new medicines in Wales: a discrete-choice experiment with assessment of external validity.
    Linley WG; Hughes DA
    Pharmacoeconomics; 2013 Apr; 31(4):345-55. PubMed ID: 23516033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of the decisions of the Israeli Public Committee for updating the National List of Health Services in 2006/2007.
    Shmueli A
    Value Health; 2009; 12(2):202-6. PubMed ID: 18657095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity and efficiency preferences of health policy makers in China--a stated preference analysis.
    Paolucci F; Mentzakis E; Defechereux T; Niessen LW
    Health Policy Plan; 2015 Oct; 30(8):1059-66. PubMed ID: 25500745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equity in HTA: what doesn't get measured, gets marginalised.
    Cookson R; Mirelman AJ
    Isr J Health Policy Res; 2017; 6():38. PubMed ID: 28694961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priority setting in the Austrian healthcare system: results from a discrete choice experiment and implications for mental health.
    Mentzakis E; Paolucci F; Rubicko G
    J Ment Health Policy Econ; 2014 Jun; 17(2):61-73. PubMed ID: 25153094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic examination of the 2006/7 update of the Israeli national list of health services].
    Shmueli A; Nissan-Englcin E
    Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining Criteria and Weights for Prioritizing Health Technologies Based on the Preferences of the General Population: A New Zealand Pilot Study.
    Sullivan T; Hansen P
    Value Health; 2017 Apr; 20(4):679-686. PubMed ID: 28408011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionals.
    Koopmanschap MA; Stolk EA; Koolman X
    Int J Technol Assess Health Care; 2010 Apr; 26(2):198-204. PubMed ID: 20392324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting priorities for the adoption of health technologies on a national level -- the Israeli experience.
    Shani S; Siebzehner MI; Luxenburg O; Shemer J
    Health Policy; 2000 Dec; 54(3):169-85. PubMed ID: 11154787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which health technologies should be funded? A prioritization framework based explicitly on value for money.
    Golan O; Hansen P
    Isr J Health Policy Res; 2012 Nov; 1(1):44. PubMed ID: 23181391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries.
    Baji P; García-Goñi M; Gulácsi L; Mentzakis E; Paolucci F
    Eur J Health Econ; 2016 Sep; 17(7):791-9. PubMed ID: 26296623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing Video Instead of In-Clinic Consultations in Primary Care in Israel: Discrete Choice Experiment Among Key Stakeholders-Patients, Primary Care Physicians, and Policy Makers.
    Chudner I; Drach-Zahavy A; Karkabi K
    Value Health; 2019 Oct; 22(10):1187-1196. PubMed ID: 31563262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring policy-makers' perspectives on disinvestment from ineffective healthcare practices.
    Elshaug AG; Hiller JE; Moss JR
    Int J Technol Assess Health Care; 2008; 24(1):1-9. PubMed ID: 18218163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 'health equity' bad for our health? A qualitative empirical ethics study of public health policy-makers' perspectives.
    Smith MJ; Thompson A; Upshur REG
    Can J Public Health; 2018 Dec; 109(5-6):633-642. PubMed ID: 30465285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priority setting for health technology adoption at the national level: Lessons learned over 25 years' experience.
    Luxenburg O; Morginstin T; Myers V; Saban M; Shemer J; Wilf-Miron R
    Int J Technol Assess Health Care; 2023 Nov; 39(1):e71. PubMed ID: 37929308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining priority for liver transplantation: a comparison of cost per QALY and discrete choice experiment-generated public preferences.
    Ratcliffe J; Buxton M; Young T; Longworth L
    Appl Health Econ Health Policy; 2005; 4(4):249-55. PubMed ID: 16466276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.
    Yazdani S; Jadidfard MP
    Health Policy Plan; 2017 May; 32(4):504-515. PubMed ID: 28025325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.